METHODS AND USE OF COMPOSITIONS COMPRISING TNF-RII(P75) AGONISTS FOR TREATING ASTHMA AND OTHER ALLERGIC CONDITIONS

摘要

The present invention is directed to methods for treating asthmatic, allergic, and Th2-mediated inflammation conditions by administering a product having TNF-RII(p75) agonist properties to a human or an animal. The use of products having TNF-RII(p75) agonist properties for the preparation of pharmaceutical compositions for treating bronchial asthma, allergic and Th2-mediated inflammation conditions in humans or animals is also provided by the invention, as well as a method for screening products having TNF-RII(p75) agonist properties comprising monitoring the inhibition of pulmonary inflammation occuring in humans or animals having pulmonary inflammation.